A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer - Monjazeb, Arta M.; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M.; Brennick, Ryan C.; Kao, Katrina Z.; Manuszak, Claire; Gentzler, Ryan D.; Tesfaye, Anteneh; Jabbour, Salma K.; Alese, Olatunji B.; Rahma, Osama E.; et al. (Clinical cancer research, 2021)
Keywords: Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; B7-H1 Antigen - antagonists & inhibitors; Biomarkers; Colorectal Neoplasms - diagnosis; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - etiology; Colorectal Neoplasms - radiotherapy; Combined Modality Therapy - methods; CTLA-4 Antigen - antagonists & inhibitors; Gene Expression Profiling; Humans; Immune Checkpoint Inhibitors - administration & dosage; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Staging; Radiation Dose Hypofractionation; Treatment Outcome